AtriCure, Inc. (ATRC)
48.98
+0.63
(+1.30%)
USD |
NASDAQ |
Sep 01, 16:00
48.98
0.00 (0.00%)
After-Hours: 20:00
AtriCure Cash from Operations (Annual) : 57.33M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 57.33M |
| December 31, 2024 | 11.14M |
| December 31, 2023 | 4.424M |
| December 31, 2022 | -22.14M |
| December 31, 2021 | -13.78M |
| December 31, 2020 | -19.90M |
| December 31, 2019 | -15.81M |
| December 31, 2018 | -4.171M |
| December 31, 2017 | -8.994M |
| December 31, 2016 | -15.12M |
| December 31, 2015 | -7.904M |
| December 31, 2014 | -21.60M |
| Date | Value |
|---|---|
| December 31, 2013 | -5.321M |
| December 31, 2012 | -1.936M |
| December 31, 2011 | -1.986M |
| December 31, 2010 | -0.0334M |
| December 31, 2009 | 0.4199M |
| December 31, 2008 | -5.710M |
| December 31, 2007 | -8.116M |
| December 31, 2006 | -12.47M |
| December 31, 2005 | -7.616M |
| December 31, 2004 | -3.800M |
| December 31, 2003 | -3.799M |
| December 31, 2002 | -5.940M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Boston Scientific Corp. | 4.534B |
| Abbott Laboratories | 9.566B |
| AngioDynamics, Inc. | 3.089M |
| Alphatec Holdings, Inc. | 45.23M |
| Baxter International, Inc. | 845.00M |